Salobir; Mateja

Patent Applications and Registrations

Patent applications and USPTO patent grants for Salobir; Mateja.The latest application filed is for "coated particles and pharmaceutical dosage forms".

Company Profile

0.6.8

Salobir; Mateja - Ljubljana SI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Coated particles and pharmaceutical dosage forms Grant 9,907,757 - Humar , et al. March 6, 2	2018-03-06
Coated Particles And Pharmaceutical Dosage Forms App 20160128946 - Humar; Vlasta ; et al.	2016-05-12
Coated particles and pharmaceutical dosage forms Grant 9,149,460 - Humar , et al. October 6, 2	2015-10-06
Stablized Pharmaceutical Composition Comprising an Amorphous Active Substance App 20090012150 - Grahek; Rok ; et al.	2009-01-08
Coated Particles and Pharmaceutical Dosage Forms App 20080138429 - HUMAR; Vlasta ; et al.	2008-06-12
Pharmaceutical compositions comprising amoxicillin and clavulanic acid App 20060159741 - Kerc; Janez ; et al.	2006-07-20
Coated particles and pharmaceutical dosage forms App 20060093680 - Humar; Vlasta ; et al.	2006-05-04
Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium Grant 7,030,151 - April 18, 2	2006-04-18
Solid pharmaceutical formulation containing lovastatin and simvastatin respectively, and its preparation Grant 6,984,399 - Pflaum , et al. January 10, 2	2006-01-10
Solid pharmaceutical formulation containing lovastatin and simvastatin respectively, and its preparation App 20040138295 - Pflaum, Zlatko ; et al.	2004-07-15
Atorvastatin calcium in a pharmaceutical form composition thereof and pharmaceutical formulation comprising atorvastatin calcium App 20040138290 - Kerc, Janet ; et al.	2004-07-15
Stablized pharmaceutical composition comprising an amorphous active substance App 20040077708 - Grahek, Rok ; et al.	2004-04-22
Solid pharmaceutical formulation containing lovastatin and simvastatin, respectively, and its preparation Grant 6,696,086 - Pflaum , et al. February 24, 2	2004-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.